Intraduodenal Delivery of Exosome-Loaded SARS-CoV-2 RBD mRNA Induces a Neutralizing Antibody Response in Mice

Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), has presented numerous challenges to global health. Vaccines, including lipid—based nanoparticle mRNA, inactivated virus, and recombined protein, have been used to prevent SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Quan, Wang, Miao, Han, Chunle, Wen, Zhijun, Meng, Xiaozhu, Qi, Dongli, Wang, Na, Du, Huanqing, Wang, Jianhong, Lu, Lu, Ge, Xiaohu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058540/
https://www.ncbi.nlm.nih.gov/pubmed/36992256
http://dx.doi.org/10.3390/vaccines11030673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058540/
https://www.ncbi.nlm.nih.gov/pubmed/36992256
http://dx.doi.org/10.3390/vaccines11030673

Ejemplares similares